TG Therapeutics
TGTX
TGTX
115 hedge funds and large institutions have $200M invested in TG Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $267M → $200M (-$66.5M)
41% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 27
Holders
115
Holding in Top 10
–
Calls
$4.51M
Puts
$2.2M
Top Buyers
| 1 | +$6.57M | |
| 2 | +$4.3M | |
| 3 | +$2.39M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$2.25M |
| 5 |
Renaissance Technologies
New York
|
+$2.15M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$4.42M | |
| 3 | -$2.49M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.39M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.3M |